PONVORY (ponesimod) for the Treatment of Multiple Sclerosis,

Clinical trials on PONVORY. The FDA approval of PONVORY was partially based on Oral Ponesimod Versus Teriflunomide In Relapsing Multiple …, Clinical trials on PONVORY. The FDA approval of PONVORY was partially based on Oral Ponesimod Versus Teriflunomide In Relapsing Multiple …, Read More

Scroll to Top